Omniscient Neurotechnology’s FDA-cleared Quicktome® platform uses machine learning to generate highly detailed, connectomic brain maps. By decoding the brain’s intricate web of connections, the technology provides clinicians with actionable intelligence to improve patient outcomes across the neuro care continuum.
Omniscient Neurotechnology’s FDA-cleared Quicktome® platform uses machine learning to generate highly detailed, connectomic brain maps. By decoding the brain’s intricate web of connections, the technology provides clinicians with actionable intelligence to improve patient outcomes across the neuro care continuum.